Prior antibiotic exposure and use of acid suppressing medications known as proton pump inhibitors (PPIs) may increase the risk for hospitalized children to contract dangerous Clostridioides difficile infections, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
“In pediatric patients, hospital-acquired infections due to C. difficile have increased over the last 20 years. However, few studies have looked at risk factors for these infections in children,” said Charles Foster, MD, a co-author and pediatric infectious diseases specialist at Cleveland Clinic Children’s. “We found that antibiotic exposure and use of proton-pump inhibitors may be risk factors. Clinicians should continue to utilize antibiotics judiciously in hospitalized children to minimize the risk of C. difficile infection.”
The incidence and healthcare burden of C. difficile infection in hospitalized children has increased in the past two decades, mostly attributed to the emergence of a new, hypervirulent strain of the bacteria. While the risk factors are well understood in adult patients, current understanding of pediatric C. difficile is complicated. Many infants and toddlers under the age of 2 are colonized with the bacteria, but do not develop clinical illness.
Researchers performed a meta-analysis and systematic review of 14 studies, including 10.5 million children, 22,320 of whom developed C. difficile infection. Based on this meta-analysis, previous antibiotic exposure and PPI use appear to be the most important risk factors associated with C. difficile infection in children. Children with prior antibiotic exposure may have approximately twice the risk of developing C. difficile infection, compared to patients without a recent history of antibiotic exposure, but the association was not statistically significant after pooling studies with only adjusted data. Researchers said that PPIs are suspected risk factors for CDI because they suppress gastric acid, which may disrupt the normal gastrointestinal microbial diversity in children.
“Physicians should remain vigilant and continue judicious use of antibiotics and PPIs in hospitalized pediatric patients to minimize the risk of C. difficile infections,” said Abhishek Deshpande, MD, PhD, a co-author and assistant professor of medicine at Cleveland Clinic Lerner College of Medicine. Dr. Deshpande has received research support from 3M, Clorox Company, and STERIS unrelated to this study.
The researchers note the limitation of this research, including use of unadjusted data. Additional high-quality epidemiologic studies are needed to better evaluate the risk factors for C. difficile in children.
Reference: Scott Anjewierden, Zheyi Han, Charles B. Foster, Chaitanya Pant, Abhishek Deshpande. “Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review.” Web (March 7, 2019).
Source: Society for Healthcare Epidemiology of America (SHEA)
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.